BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT05531786-completion@plaintrial.com
DTSTAMP:20261027T144918Z
DTSTART;VALUE=DATE:20270722
SUMMARY:Phase I/II Study of Pacritinib\, A JAK2/IRAK1/CSF1R Inhibitor\, in 
 Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hema
 topoietic Stem Cell Transplantation (HSCT) — estimated completion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT05531786
URL:https://plaintrial.com/trial/NCT05531786
END:VEVENT
END:VCALENDAR